The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study – 6 month results

被引：0
|
作者：
Arshad M. Khanani
Aamir A. Aziz
Hannah Khan
Ashwin Gupta
Ohidul Mojumder
Aigerim Saulebayeva
Ashkan M. Abbey
David R. P. Almeida
Robert L. Avery
Himanshu K. Banda
Mark R. Barakat
Ramanath Bhandari
Emmanuel Y. Chang
Sara J. Haug
Nikolas J. S. London
Luke Mein
Veeral S. Sheth
Jeremy D. Wolfe
Michael A. Singer
Carl J. Danzig
机构：
[1] Sierra Eye Associates,
[2] University of Nevada,undefined
[3] Reno School of Medicine,undefined
[4] Vanderbilt University School of Medicine,undefined
[5] Texas Retina Associates,undefined
[6] Erie Retinal Surgery,undefined
[7] California Retina Consultants,undefined
[8] Sound Retina,undefined
[9] Retinal Consultants of Arizona,undefined
[10] Springfield Clinic Eye Institute,undefined
[11] Retina & Vitreous of Texas,undefined
[12] Southwest Eye Consultants,undefined
[13] Retina Consultants San Diego,undefined
[14] Medical Center Ophthalmology Associates,undefined
[15] University Retina,undefined
[16] Associated Retinal Consultants,undefined
[17] Rand Eye Institute,undefined
来源：
Eye | 2023年 / 37卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3574 / 3581
页数：7
相关论文
共 50 条
  • [1] The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study-6 month results
    Khanani, Arshad M.
    Aziz, Aamir A.
    Khan, Hannah
    Gupta, Ashwin
    Mojumder, Ohidul
    Saulebayeva, Aigerim
    Abbey, Ashkan M.
    Almeida, David R. P.
    Avery, Robert L.
    Banda, Himanshu K.
    Barakat, Mark R.
    Bhandari, Ramanath
    Chang, Emmanuel Y.
    Haug, Sara J.
    London, Nikolas J. S.
    Mein, Luke
    Sheth, Veeral S.
    Wolfe, Jeremy D.
    Singer, Michael A.
    Danzig, Carl J.
    [J]. EYE, 2023, 37 (17) : 3574 - 3581
  • [2] The Real-World Efficacy and Safety of Faricimab in Neovascular Age-Related Macular Degeneration: The TRUCKEE Study
    Aziz, Aamir Abdul
    Khan, Hannah
    Abbey, Ashkan Michael
    Almeida, David R. P.
    Avery, Robert L.
    Banda, Himanshu K.
    Barakat, Mark
    Bhandari, Ramanath
    Chang, Emmanuel Y.
    Haug, Sara
    London, Nikolas J. S.
    Sheth, Veeral
    Wolfe, Jeremy
    Singer, Michael Andrew
    Danzig, Carl J.
    Khanani, Arshad M.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [3] Real-world efficacy of intravitreal faricimab for neovascular age-related macular degeneration: a systematic review
    Nasimi, Nasratullah
    Nasimi, Safiullah
    Grauslund, Jakob
    Vergmann, Anna Stage
    Subhi, Yousif
    [J]. INTERNATIONAL JOURNAL OF RETINA AND VITREOUS, 2024, 10 (01)
  • [4] Real-World Outcomes of Faricimab Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
    Quah, Nicole Q. X.
    Javed, Khawaja Muhammad Ammar Ali
    Arbi, Lamees
    Hanumunthadu, Daren
    [J]. CLINICAL OPHTHALMOLOGY, 2024, 18 : 1479 - 1490
  • [5] Real-World Weekly Efficacy Analysis of Faricimab in Patients with Age-Related Macular Degeneration
    Muth, Daniel R.
    Fasler, Katrin F.
    Kvanta, Anders
    Rejdak, Magdalena
    Blaser, Frank
    Zweifel, Sandrine A.
    [J]. BIOENGINEERING-BASEL, 2024, 11 (05):
  • [6] Eligibility for faricimab in a real-world neovascular age-related macular degeneration population: a cross-sectional study
    Jern, Irene
    Forsell, Sara
    Norberg, Helena
    [J]. BMJ OPEN, 2022, 12 (09):
  • [7] Real-world study to evaluate the efficacy and safety of intravitreal brolucizumab for refractory neovascular age-related macular degeneration
    Hoseok Yeom
    Hye Ji Kwon
    Yoon Jeon Kim
    Junyeop Lee
    Young Hee Yoon
    Joo Yong Lee
    [J]. Scientific Reports, 13
  • [8] Real-world study to evaluate the efficacy and safety of intravitreal brolucizumab for refractory neovascular age-related macular degeneration
    Yeom, Hoseok
    Kim, Yoon Jeon
    Lee, Junyeop
    Yoon, Young Hee
    Lee, Joo Yong
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [9] Real-world study to evaluate the efficacy and safety of intravitreal brolucizumab for refractory neovascular age-related macular degeneration
    Yeom, Hoseok
    Kwon, Hye Ji
    Kim, Yoon Jeon
    Lee, Junyeop
    Yoon, Young Hee
    Lee, Joo Yong
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)
  • [10] Real-World Data on Faricimab Switching in Treatment-Refractory Neovascular Age-Related Macular Degeneration
    Ng, Benjamin
    Kolli, Hema
    Kumar, Naduviledeth Ajith
    Azzopardi, Matthew
    Logeswaran, Abison
    Buensalido, Julius
    Mushtaq, Bushra
    Chavan, Randhir
    Chong, Yu Jeat
    [J]. LIFE-BASEL, 2024, 14 (02):
12345